Literature DB >> 30664553

Antibiotics Versus No Antibiotics for Acute Uncomplicated Diverticulitis: A Systematic Review and Meta-analysis.

Madhav Desai1, Jihan Fathallah1, Venkat Nutalapati1, Shreyas Saligram2.   

Abstract

BACKGROUND: Antibiotics are routinely used for diverticulitis irrespective of severity. Current practice guidelines favor against the use of antibiotics for acute uncomplicated diverticulitis.
OBJECTIVE: We performed a systematic review and meta-analysis to examine the role of antibiotic use in an episode of uncomplicated diverticulitis. DATA SOURCES: PubMed/Medline, Embase, Scopus, and Cochrane were used. STUDY SELECTION: Eligible studies included those with patients with uncomplicated diverticulitis receiving any antibiotics compared with patients not receiving any antibiotics (or observed alone). MAIN OUTCOME MEASURES: Pooled odds rate of total complications, treatment failure, recurrent diverticulitis, readmission rate, sigmoid resection, mortality rate, and length of stay were measured.
RESULTS: Of 1050 citations reviewed, 7 studies were eligible for the analysis. There were total of 2241 patients: 895 received antibiotics (mean age = 59.1 y; 38% men) and 1346 did not receive antibiotics (mean age = 59.4 y; 37% men). Antibiotics were later added in 2.7% patients who initially were observed off antibiotics. Length of hospital stay was not significantly different among either group (no antibiotics = 3.1 d vs antibiotics = 4.5 d; p = 0.20). Pooled rate of recurrent diverticulitis was not significantly different among both groups (pooled OR = 1.27 (95%, CI 0.90-1.79); p = 0.18). Rate of total complications (pooled OR = 1.99 (95% CI, 0.66-6.01); p = 0.22), treatment failure (pooled OR = 0.68 (95% CI, 0.42-1.09); p = 0.11), readmissions (pooled OR = 0.75 (95% CI, 0.44-1.30); p = 0.31). and patients who required sigmoid resection (pooled OR = 3.37 (95% CI, 0.65-17.34); p = 0.15) were not significantly different among patients who received antibiotics and those who did not. Mortality rates were 4 of 1310 (no-antibiotic group) versus 4 of 863 (antibiotic group). LIMITATIONS: Only 2 randomized controlled studies were available and there was high heterogeneity in existing data.
CONCLUSIONS: This meta-analysis of current literature shows that patients with uncomplicated diverticulitis can be monitored off antibiotics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30664553     DOI: 10.1097/DCR.0000000000001324

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Conservative treatment of uncomplicated right-sided diverticulitis: a systematic review and meta-analysis.

Authors:  Jun Ho Lee; Byung Kyu Ahn; Kang Hong Lee
Journal:  Int J Colorectal Dis       Date:  2021-03-25       Impact factor: 2.571

Review 2.  Antibiotics for uncomplicated diverticulitis.

Authors:  Marie-Louise Dichman; Steffen Jais Rosenstock; Daniel M Shabanzadeh
Journal:  Cochrane Database Syst Rev       Date:  2022-06-22

Review 3.  Colonic diverticular disease.

Authors:  Antonio Tursi; Carmelo Scarpignato; Lisa L Strate; Angel Lanas; Wolfgang Kruis; Adi Lahat; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-03-26       Impact factor: 52.329

4.  Management of acute uncomplicated diverticulitis without antibiotics: compliance and outcomes -a retrospective cohort study.

Authors:  Najia Azhar; Hager Aref; Adam Brorsson; Marie-Louise Lydrup; Fredrik Jörgren; Johannes Kurt Schultz; Pamela Buchwald
Journal:  BMC Emerg Med       Date:  2022-02-21

5.  Investigation of the clinical features and recurrence patterns of acute right-sided colonic diverticulitis: A retrospective cohort study.

Authors:  Moon Young Oh; Rumi Shin; Seung Chul Heo; Han-Ki Lim; Min Jung Kim; Ji Won Park; Seung-Bum Ryoo; Seung-Yong Jeong; Kyu Joo Park
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18

6.  Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study.

Authors:  Mohammadreza Salehi; Hossein Khalili; Arash Seifi; Hamidreza Davoudi; Ilad Alavi Darazam; Zahra Jahangard-Rafsanjani; Esmaeil Mohammadnejad; Behrooz Heydari; SaeedReza Jamali Moghadam Siahkaly; Payam Tabarsi; Saeed Kalantari; Seyed Ali Dehghan Menshadi; Farhang Babamahmoodi; Farzin Khorvash; Mohammad Ali Davarpanah; Rasool Soltani; Mojtaba Hedayat Yaghoobi; Seyed Alireza Mosavi Anari; Javad Khodadadi; Amir Aliramezani; Sedigheh Hantooshzadeh; Hamid Reza Naderi; Mahboobeh Hajiabdolbaghi; Sepideh Elyasi; Dena Firouzabadi; Hamideh Abbaspour Kasgari; Soheil Roshanzamiri; Sholeh Ebrahimpour
Journal:  J Clin Pharm Ther       Date:  2022-08-21       Impact factor: 2.145

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.